These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21776025)

  • 1. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
    Cheng B; Ling C; Dai Y; Lu Y; Glushakova LG; Gee SW; McGoogan KE; Aslanidi GV; Park M; Stacpoole PW; Siemann D; Liu C; Srivastava A; Ling C
    Gene Ther; 2012 Apr; 19(4):375-84. PubMed ID: 21776025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors.
    Ling C; Lu Y; Cheng B; McGoogan KE; Gee SW; Ma W; Li B; Aslanidi GV; Srivastava A
    J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3.
    Ling C; Lu Y; Kalsi JK; Jayandharan GR; Li B; Ma W; Cheng B; Gee SW; McGoogan KE; Govindasamy L; Zhong L; Agbandje-McKenna M; Srivastava A
    Hum Gene Ther; 2010 Dec; 21(12):1741-7. PubMed ID: 20545554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo.
    Yin L; Keeler GD; Zhang Y; Hoffman BE; Ling C; Qing K; Srivastava A
    Gene Ther; 2021 Aug; 28(7-8):422-434. PubMed ID: 32152434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
    Zhong L; Li B; Mah CS; Govindasamy L; Agbandje-McKenna M; Cooper M; Herzog RW; Zolotukhin I; Warrington KH; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7827-32. PubMed ID: 18511559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.
    Song L; Li X; Jayandharan GR; Wang Y; Aslanidi GV; Ling C; Zhong L; Gao G; Yoder MC; Ling C; Tan M; Srivastava A
    PLoS One; 2013; 8(3):e58757. PubMed ID: 23516552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses.
    Ling C; Li B; Ma W; Srivastava A
    Hum Gene Ther Methods; 2016 Aug; 27(4):143-9. PubMed ID: 27431826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model.
    Ling C; Wang Y; Zhang Y; Ejjigani A; Yin Z; Lu Y; Wang L; Wang M; Li J; Hu Z; Aslanidi GV; Zhong L; Gao G; Srivastava A; Ling C
    Hum Gene Ther; 2014 Dec; 25(12):1023-34. PubMed ID: 25296041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors.
    Ling C; Yin Z; Li J; Zhang D; Aslanidi G; Srivastava A
    Mol Ther Methods Clin Dev; 2016; 3():16029. PubMed ID: 27200382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B.
    Brown HC; Doering CB; Herzog RW; Ling C; Markusic DM; Spencer HT; Srivastava A; Srivastava A
    Hum Gene Ther; 2020 Oct; 31(19-20):1114-1123. PubMed ID: 32657150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.
    Chen M; Maeng K; Nawab A; Francois RA; Bray JK; Reinhard MK; Boye SL; Hauswirth WW; Kaye FJ; Aslanidi G; Srivastava A; Zajac-Kaye M
    Hum Gene Ther Methods; 2017 Feb; 28(1):49-59. PubMed ID: 28125909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.
    Li M; Jayandharan GR; Li B; Ling C; Ma W; Srivastava A; Zhong L
    Hum Gene Ther; 2010 Nov; 21(11):1527-43. PubMed ID: 20507237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.
    Sayroo R; Nolasco D; Yin Z; Colon-Cortes Y; Pandya M; Ling C; Aslanidi G
    Gene Ther; 2016 Jan; 23(1):18-25. PubMed ID: 26270885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
    Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
    Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
    Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.
    Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE
    Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.
    Song L; Kauss MA; Kopin E; Chandra M; Ul-Hasan T; Miller E; Jayandharan GR; Rivers AE; Aslanidi GV; Ling C; Li B; Ma W; Li X; Andino LM; Zhong L; Tarantal AF; Yoder MC; Wong KK; Tan M; Chatterjee S; Srivastava A
    Cytotherapy; 2013 Aug; 15(8):986-98. PubMed ID: 23830234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.
    Rutledge EA; Halbert CL; Russell DW
    J Virol; 1998 Jan; 72(1):309-19. PubMed ID: 9420229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
    Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
    Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.
    Li S; Ling C; Zhong L; Li M; Su Q; He R; Tang Q; Greiner DL; Shultz LD; Brehm MA; Flotte TR; Mueller C; Srivastava A; Gao G
    Mol Ther; 2015 Dec; 23(12):1867-76. PubMed ID: 26403887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.